One top takeaway from a recent conference focused on the need for health systems—not just startups—to adopt an entrepreneurial mindset. “The path to growth will be a roller coaster. Stay the course,” panelists encouraged.
Yet for many health system leaders, making the move to a more…
Source: medcitynews.com – Read more
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
